Literature DB >> 11342756

Prognostic value of heart rate variability in time domain analysis in congestive heart failure.

S Boveda1, M Galinier, A Pathak, J Fourcade, B Dongay, D Benchendikh, P Massabuau, J M Fauvel, J M Senard, J P Bounhoure.   

Abstract

AIMS: Analysis of heart rate variability is a noninvasive tool that allows to study autonomic control of the heart. Several studies have shown disturbed heart rate variability in patients with chronic heart failure (CHF). We sought to assess the prognostic value of time domain measures of heart rate variability in CHF. METHODS AND
RESULTS: We prospectively enrolled 190 patients with CHF in sinus rhythm, mean age 61+/-12 years, 109 (57.4 %) in NYHA class II and 81 (42.6 %) in class III or IV, mean cardiothoracic ratio 57.6+/-6.4 % and mean left ventricular ejection fraction 28.2+/-8.8 %, 85 (45 %) with ischemic and 105 (55 %) with idiopathic dilated cardiomyopathy. Time domain measures of heart rate variability were obtained from 24 h Holter ECG recordings. During follow-up (22+/-18 months), 55 patients died. In multivariate analysis, independent predictors for all-cause mortality were: ischemic heart disease, cardiothoracic ratio > or =60 % and standard deviation of all normal RR intervals <67 ms (RR=2.5, 95 % CI 1.5--4.2).
CONCLUSIONS: Depressed heart rate variability has independent prognostic value in patients with CHF.

Entities:  

Mesh:

Year:  2001        PMID: 11342756     DOI: 10.1023/a:1011485609838

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  32 in total

1.  Decreased spontaneous heart rate variability in congestive heart failure.

Authors:  G Casolo; E Balli; T Taddei; J Amuhasi; C Gori
Journal:  Am J Cardiol       Date:  1989-11-15       Impact factor: 2.778

2.  Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value.

Authors:  L Fauchier; D Babuty; P Cosnay; M L Autret; J P Fauchier
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

3.  Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training.

Authors:  S Adamopoulos; P Ponikowski; E Cerquetani; M Piepoli; G Rosano; P Sleight; A J Coats
Journal:  Eur Heart J       Date:  1995-10       Impact factor: 29.983

4.  Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm?

Authors:  M L Slatton; W N Irani; S A Hall; L G Marcoux; R L Page; P A Grayburn; E J Eichhorn
Journal:  J Am Coll Cardiol       Date:  1997-05       Impact factor: 24.094

5.  Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy.

Authors:  B M Szabó; D J van Veldhuisen; N van der Veer; J Brouwer; P A De Graeff; H J Crijns
Journal:  Am J Cardiol       Date:  1997-04-01       Impact factor: 2.778

6.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

Authors:  K Swedberg; P Eneroth; J Kjekshus; L Wilhelmsen
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

Review 7.  Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal.

Authors:  G Parati; J P Saul; M Di Rienzo; G Mancia
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

8.  Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function.

Authors:  J Nolan; A D Flapan; S Capewell; T M MacDonald; J M Neilson; D J Ewing
Journal:  Br Heart J       Date:  1992-06

9.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

10.  Effects of bisoprolol on heart rate variability in heart failure.

Authors:  F Pousset; X Copie; P Lechat; P Jaillon; J P Boissel; M Hetzel; F Fillette; W Remme; L Guize; J Y Le Heuzey
Journal:  Am J Cardiol       Date:  1996-03-15       Impact factor: 2.778

View more
  9 in total

Review 1.  Heart rate variability and cardiovascular mortality.

Authors:  Rollo P Villareal; Brant C Liu; Ali Massumi
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

2.  Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients?

Authors:  Tamara O Thomas; John L Jefferies; Angela Lorts; Jeffrey B Anderson; Zhiqian Gao; D Woodrow Benson; Kan N Hor; Linda H Cripe; Elaine M Urbina
Journal:  Pediatr Cardiol       Date:  2014-11-16       Impact factor: 1.655

3.  Exercise training improves heart rate variability in older patients with heart failure: a randomized, controlled, single-blinded trial.

Authors:  Khalil Murad; Peter H Brubaker; David M Fitzgerald; Timothy M Morgan; David C Goff; Elsayed Z Soliman; Joel D Eggebeen; Dalane W Kitzman
Journal:  Congest Heart Fail       Date:  2012-04-26

4.  Autonomic function in sleep apnea patients: increased heart rate variability except during REM sleep in obese patients.

Authors:  Erica B Reynolds; Gilbert Seda; J C Ware; Aaron I Vinik; Marcelo R Risk; Nancy F Fishback
Journal:  Sleep Breath       Date:  2007-03       Impact factor: 2.816

Review 5.  Heart rate variability and swimming.

Authors:  Julian Koenig; Marc N Jarczok; Mieke Wasner; Thomas K Hillecke; Julian F Thayer
Journal:  Sports Med       Date:  2014-10       Impact factor: 11.136

6.  Heart rate variability analysis in general medicine.

Authors:  Yi Gang; Marek Malik
Journal:  Indian Pacing Electrophysiol J       Date:  2003-01-01

7.  Effects of eurythmy therapy in the treatment of essential arterial hypertension: a pilot study.

Authors:  Roland Zerm; Ronald Zerm; Froeydis Lutnæs-Mast; Heiner Mast; Matthias Girke; Matthias Kröz
Journal:  Glob Adv Health Med       Date:  2013-01

8.  Short-term vs. long-term heart rate variability in ischemic cardiomyopathy risk stratification.

Authors:  Andreas Voss; Rico Schroeder; Montserrat Vallverdú; Steffen Schulz; Iwona Cygankiewicz; Rafael Vázquez; Antoni Bayés de Luna; Pere Caminal
Journal:  Front Physiol       Date:  2013-12-13       Impact factor: 4.566

9.  Dose-response relationship between very vigorous physical activity and cardiovascular health assessed by heart rate variability in adults: Cross-sectional results from the EPIMOV study.

Authors:  Thiago Luís Wanderley de Sousa; Thatiane Lopes Valentim di Paschoale Ostoli; Evandro Fornias Sperandio; Rodolfo Leite Arantes; Antônio Ricardo de Toledo Gagliardi; Marcello Romiti; Rodrigo Pereira da Silva; Victor Zuniga Dourado
Journal:  PLoS One       Date:  2019-01-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.